MedTrace Logo

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

NCT07478328 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-17

No results posted yet for this study

Summary

This study explores whether Chaigui Longmu Ejiao Paste can reduce the average weekly number of angina attacks in patients with ischemic heart disease after 8 weeks of treatment, using Chaigui Longmu Paste without Ejiao as a parallel control and incorporating a synthesized external control.

Conditions

  • Ischemic Heart Disease

Interventions

DRUG

Standard Western medicine treatment + Chaigui Longmu Ejiao Paste

15 g orally twice daily

DRUG

Placebo Comparator: Standard Western medicine treatment + Chaigui Longmu Paste without Ejiao

15 g orally twice daily

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    collaborator OTHER

  • Innovation Research Institute of Traditional Chinese Medicine Shanghai University of Traditional Chinese Medicine

    collaborator UNKNOWN

  • Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine

    collaborator UNKNOWN

  • Center for Pharmacometrics, Shanghai University of Traditional Chinese Medicine

    collaborator UNKNOWN

  • DongE E Jiao Coporation Limited

    collaborator INDUSTRY

  • Longhua Hospital

    lead OTHER

Principal Investigators

  • Su yun Yuan, Ph.D · Shanghai University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-08
Primary Completion
2027-03-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07478328 on ClinicalTrials.gov